About
Mission/Vision
Our Team
Board of Directors
Elite Members
Why Utah?
Life Sciences Report
Partnerships
Jobs
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Life Sciences Jobs
Member Discounts
Non-dilutive Funding
Membership Directory
Advocacy
News/Info
Biosphere Magazine
Life Sciences News
Reports/Publications
Podcasts
Events
BioUtah Events
Industry Events
Newsletter
Biosphere
Magazine
About
Mission/Vision
Our Team
Board of Directors
Elite Members
Why Utah?
Life Sciences Report
Partnerships
Jobs
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Life Sciences Jobs
Member Discounts
Non-dilutive Funding
Membership Directory
Advocacy
News/Info
Biosphere Magazine
Life Sciences News
Reports/Publications
Podcasts
Events
BioUtah Events
Industry Events
Newsletter
Biosphere
Magazine
Join Now
Utah Life Sciences News & Events
July 25, 2025
July 31, 2025
This week’s newsletter included:
Nestmedic Selects Curavit Clinical Research
Wasatch Health Announces $150M Structured Capital Fund
Improving Women’s Health: MobileODT Joins Liger Medical
How Salt Lake City’s Decision to Transfer its Foreign Trade Zone Authority Became ‘Fortuitous’
Light Line Medical’s Peritoneal Dialysis PhotoDisinfection System Featured
Huntsman Cancer Institute Annual Awards
Seek Labs Adds Veterinary Diseases to Global Disease Atlas
Kelly Himle Joins ATL as Global Director of Marketing
TechBuzz
Features Purgo Scientific in Article
Stanford Faculty Member George Tidmarsh, MD, PhD, Named Director of FDA’s CDER
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting
BioUtah Members: We’re Upgrading Our CRM
U of U Founders Day Distinguished Alumni Awards
Utah Business
Opens Nominations for 2025 Best Companies to Work For Awards
Brain-to-Text ’25 Competition
Recent News
Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications
Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment
World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing
SINTX 2025 Highlights
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)